Which pharmacokinetic changes in older adults necessitate careful dosing and monitoring?

Study for the NMNC 4320 Professional Nursing Concepts Test. Access flashcards and multiple choice questions, each with hints and explanations. Enhance your readiness for exam success!

Multiple Choice

Which pharmacokinetic changes in older adults necessitate careful dosing and monitoring?

Explanation:
Aging brings predictable changes in pharmacokinetics that require careful dosing and monitoring to maintain effectiveness while avoiding toxicity. All four processes—absorption, distribution, metabolism, and excretion—can be altered in older adults. Absorption may be slower or altered due to changes in gastric emptying and pH; distribution shifts because body composition changes (more fat, less total body water and lean mass) affect how drugs spread and reach target tissues; metabolism can slow with reduced hepatic blood flow and liver mass, lengthening the time a drug stays active; excretion commonly declines with reduced kidney function, raising the potential for drug buildup. Because of these intertwined changes, dosing often needs adjustment and closer monitoring is essential. Other statements imply there are no pharmacokinetic changes with aging, that PK is uniform across ages, or that drug clearance improves with age, which contradicts how aging actually affects drug processing.

Aging brings predictable changes in pharmacokinetics that require careful dosing and monitoring to maintain effectiveness while avoiding toxicity. All four processes—absorption, distribution, metabolism, and excretion—can be altered in older adults. Absorption may be slower or altered due to changes in gastric emptying and pH; distribution shifts because body composition changes (more fat, less total body water and lean mass) affect how drugs spread and reach target tissues; metabolism can slow with reduced hepatic blood flow and liver mass, lengthening the time a drug stays active; excretion commonly declines with reduced kidney function, raising the potential for drug buildup. Because of these intertwined changes, dosing often needs adjustment and closer monitoring is essential.

Other statements imply there are no pharmacokinetic changes with aging, that PK is uniform across ages, or that drug clearance improves with age, which contradicts how aging actually affects drug processing.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy